compound
Semaglutide (20mg Vial) Questions Answered
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist with a prolonged half-life of approximately 7 days [1] , approved for chronic weight management and glycemic control.
Semaglutide (20mg Vial)
Week Weekly Dose Units (per injection) (mL) Weeks 1–4 250 mcg (0.25 mg) 4 units (0.04 mL) Weeks 5–8 500 mcg (0.5 mg) 7.5 units (0.075 mL) Weeks 9–12 1000 mcg (1.0 mg) 15 units (0.15 mL) Weeks 13–16 1700 mcg (1.7 mg) 25.5 units (0.255 mL) Weeks 17+ (Maintena...
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist with a prolonged half-life of approximately 7 days [1] , approved for chronic weight management and glycemic control.
Week Weekly Dose Units (per injection) (mL) Weeks 1–4 250 mcg (0.25 mg) 4 units (0.04 mL) Weeks 5–8 500 mcg (0.5 mg) 7.5 units (0.075 mL) Weeks 9–12 1000 mcg (1.0 mg) 15 units (0.15 mL) Weeks 13–16 1700 mcg (1.7 mg) 25.5 units (0.255 mL) Weeks 17+ (Maintena...
Plan based on an 8–20 week weekly titration protocol. Peptide Vials (Semaglutide, 20 mg each): 8 weeks ≈ 1 vial (3 mg total used) 12 weeks ≈ 1 vial (7 mg total used) 16 weeks ≈ 1 vial (13.8 mg total used) 20 weeks ≈ 2 vials (23.4 mg total used with maintena...
Proper storage preserves peptide quality and efficacy [7] [8] . Lyophilized (powder): Store at −20 °C (−4 °F) in a cool, dry place protected from light.